The World Health Organization plans to officially back the use of weight-loss drugs to treat obesity in adults for the first ...

Hims & Hers launched a pharmacy-made weight-loss drug last year, taking advantage of an FDA rule allowing it to temporarily ...

The WHO announced its plan to support GLP-1 weight-loss drugs, like Wegovy and Zepbound, to address the global obesity epidemic, according to Reuters.

More than 2.5 billion adults worldwide are currently overweight or obese, according to estimates from the World Health ...

Many Americans are taking GLP1 medications, which include weight loss and diabetes medications Ozempic and Wegovy.

Pfizer has ended its development of danuglipron, its oral weight-loss drug. (Image Credits: Reuters) Pfizer said on Monday it has discontinued development of experimental weight-loss pill ...

Eli Lilly announced clinical trial results this week for a daily pill to treat obesity and diabetes. Its name is absolutely ...

WEIGHTWATCHERS CEO SIMA SISTANI OUT IN ABRUPT EXIT, EMBRACED WEIGHT LOSS DRUGS "While we are disappointed to discontinue the development of danuglipron, we remain committed to evaluating and ...

Iuliia Burmistrova/Getty Images GLP-1 drugs have helped people successfully achieve and maintain weight loss; however, losing muscle has been a significant concern. New research suggests that ...

Recent findings presented at the European Congress on Obesity (ECO) in Malaga, Spain, reveal that the drug leads to significant and lasting weight loss over three years. This could change how ...

Eli Lilly, maker of Mounjaro, also offers another version of the drug called Zepbound, which is the same medication approved for weight loss, chronic weight management and sleep apnea. Other GLP-1 ...

Women demonstrated greater and more sustained weight loss, highlighting the drug's potential for long-term weight management. In the trial, women on weight loss drugs lost an average of 31 per ...